Energetics of Pathogenic Bacteria and Opportunities for Drug Development

Advances in Microbial Physiology

Volumn 65, Issue , 2014, Pages 1-62

  Cook, Gregory M ^a,b   Greening, Chris ^a   Hards, Kiel ^a   Berney, Michael ^c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Bacterial energetics; Drug targets; Pathogenic bacteria; Physiology; Respiration

Indexed keywords

ANTIINFECTIVE AGENT; COPPER; CYTOCHROME; CYTOCHROME B; CYTOCHROME D; FORMATE DEHYDROGENASE; FUMARATE REDUCTASE; HEME; HYDROGENASE; NITRATE REDUCTASE; NITRITE REDUCTASE; OXIDOREDUCTASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUCCINATE DEHYDROGENASE; TETRATHIONIC ACID; VALINOMYCIN; BACTERIAL PROTEIN;

ARTICLE; BACTERIAL CELL; CAMPYLOBACTER JEJUNI; CELL ENERGY; DENITRIFICATION; DRUG DEVELOPMENT; DRUG TARGETING; ENERGY TRANSFER; ESCHERICHIA COLI; FUSOBACTERIUM NUCLEATUM; HELICOBACTER PYLORI; HUMAN; IMMUNITY; MICROFLORA; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NONHUMAN; OXYGEN TENSION; PROTON MOTIVE FORCE; PROTON TRANSPORT; PSEUDOMONAS AERUGINOSA; RESPIRATORY CHAIN; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS; TREPONEMA PALLIDUM; ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIUM; CHEMISTRY; DRUG EFFECTS; ENERGY METABOLISM; METABOLISM;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER JEJUNI; FUSOBACTERIUM NUCLEATUM; MYCOBACTERIUM TUBERCULOSIS; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PROTEINS; DRUG DISCOVERY; DRUG RESISTANCE, BACTERIAL; ENERGY METABOLISM; HUMANS; OXIDOREDUCTASES; PROTON-MOTIVE FORCE;

EID: 84919492563     PISSN: 00652911     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ampbs.2014.08.001     Document Type: Chapter

References (323)

1. Abrahams K.A., Cox J.A., Spivey V.L., Loman N.J., Pallen M.J., Constantinidou C., et al. Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB. PLoS One 2012, 7:e52951.
2. 1-ATPase from bovine heart mitochondria. Nature 1994, 370:621-628.
3. Akhtar S., Khan A., Sohaskey C.D., Jagannath C., Sarkar D. Nitrite reductase NirBD is induced and plays an important role during in vitro dormancy of Mycobacterium tuberculosis. Journal of Bacteriology 2013, 195:4592-4599.
4. Alvarez-Ortega C., Harwood C.S. Responses of Pseudomonas aeruginosa to low oxygen indicate that growth in the cystic fibrosis lung is by aerobic respiration. Molecular Microbiology 2007, 65:153-165.
5. Amaral L., Kristiansen J.E., Abebe L.S., Millett W. Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: Potential use for initial therapy of freshly diagnosed tuberculosis. Journal of Antimicrobial Chemotherapy 1996, 38:1049-1053.
6. Amaral L., Viveiros M., Kristiansen J.E. "Non-Antibiotics": Alternative therapy for the management of MDRTB and MRSA in economically disadvantaged countries. Current Drug Targets 2006, 7:887-891.
7. Andries K., Verhasselt P., Guillemont J., Göhlmann H.W.H., Neefs J.-M., Winkler H., et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005, 307:223-227.
8. Anjum M.F., Stevanin T.M., Read R.C., Moir J.W. Nitric oxide metabolism in Neisseria meningitidis. Journal of Bacteriology 2002, 184:2987-2993.
9. Arai H. Regulation and function of versatile aerobic and anaerobic respiratory metabolism in Pseudomonas aeruginosa. Frontiers in Microbiology 2011, 2:103.
10. Arai H., Kodama T., Igarashi Y. Cascade regulation of the two CRP/FNR-related transcriptional regulators (ANR and DNR) and the denitrification enzymes in Pseudomonas aeruginosa. Molecular Microbiology 1997, 25:1141-1148.
11. Arya S., Sethi D., Singh S., Hade M.D., Singh V., Raju P., et al. Truncated hemoglobin, HbN, is post-translationally modified in Mycobacterium tuberculosis and modulates host-pathogen interactions during intracellular infection. Journal of Biological Chemistry 2013, 288:29987-29999.
12. Aspholm M., Aas F.E., Harrison O.B., Quinn D., Vik A., Viburiene R., et al. Structural alterations in a component of cytochrome c oxidase and molecular evolution of pathogenic Neisseria in humans. PLoS Pathogens 2010, 6:e1001055.
13. Bader M., Muse W., Ballou D.P., Gassner C., Bardwell J.C. Oxidative protein folding is driven by the electron transport system. Cell 1999, 98:217-227.
14. Baek S.-H., Li A.H., Sassetti C.M. Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biology 2011, 9:e1001065.
15. Bakken V., Hogh B.T., Jensen H.B. Utilization of amino acids and peptides by Fusobacterium nucleatum. Scandinavian Journal of Dental Research 1989, 97:43-53.
16. Balemans W., Vranckx L., Lounis N., Pop O., Guillemont J., Vergauwen K., et al. Novel antibiotics targeting respiratory ATP synthesis in Gram-positive pathogenic bacteria. Antimicrobial Agents and Chemotherapy 2012, 56:4131-4139.
17. Baradaran R., Berrisford J.M., Minhas G.S., Sazanov L.A. Crystal structure of the entire respiratory complex I. Nature 2013, 494:443-448.
18. Barker H.C., Kinsella N., Jaspe A., Friedrich T., O'Connor C.D. Formate protects stationary-phase Escherichia coli and Salmonella cells from killing by a cationic antimicrobial peptide. Molecular Microbiology 2000, 35:1518-1529.
19. Batista A.P., Marreiros B.C., Pereira M.M. The role of proton and sodium ions in energy transduction by respiratory complex I. IUBMB Life 2012, 64:492-498.
20. Baughn A.D., Malamy M.H. The strict anaerobe Bacteroides fragilis grows in and benefits from nanomolar concentrations of oxygen. Nature 2004, 427:441-444.
21. Beatrix B., Bendrat K., Rospert S., Buckel W. The biotin-dependent sodium ion pump glutaconyl-CoA decarboxylase from Fusobacterium nucleatum (subsp. nucleatum). Comparison with the glutaconyl-CoA decarboxylases from gram-positive bacteria. Archives of Microbiology 1990, 154:362-369.
22. Bebbington K.J., Williams H.D. Investigation of the role of the cydD gene product in production of a functional cytochrome d oxidase in Escherichia coli. FEMS Microbiology Letters 1993, 112:19-24.
23. Becker D., Selbach M., Rollenhagen C., Ballmaier M., Meyer T.F., Mann M., et al. Robust Salmonella metabolism limits possibilities for new antimicrobials. Nature 2006, 440:303-307.
24. Begum A., Rahman M.M., Ogawa W., Mizushima T., Kuroda T., Tsuchiya T. Gene cloning and characterization of four MATE family multidrug efflux pumps from Vibrio cholerae Non-O1. Microbiology and Immunology 2005, 49:949-957.
25. Benoit S.L., Maier R.J. Hydrogen and nickel metabolism in Helicobacter species. Annals of the New York Academy of Sciences 2008, 1125:242-251.
26. Benoit S.L., Maier R.J. Twin-arginine translocation system in Helicobacter pylori: TatC, but not TatB, is essential for viability. mBio 2014, 5:e01016-13.
27. Bereswill S., Fischer A., Plickert R., Haag L.M., Otto B., Kuhl A.A., et al. Novel murine infection models provide deep insights into the "menage a trois" of Campylobacter jejuni, microbiota and host innate immunity. PLoS One 2011, 6:e20953.
28. Berney M., Cook G.M. Unique flexibility in energy metabolism allows mycobacteria to combat starvation and hypoxia. PLoS One 2010, 5:e8614.
29. Berney M., Greening C., Hards K., Collins D., Cook G.M. Three different [NiFe] hydrogenases confer metabolic flexibility in the obligate aerobe Mycobacterium smegmatis. Environmental Microbiology 2014, 16:318-330.
30. Berney M., Greening C., Conrad R., Jacobs W.R., Cook G.M. An obligately aerobic soil bacterium activates fermentative hydrogen production to survive reductive stress during hypoxia. Proceedings of the National Academy of Sciences of the United States of America 2014, 111:11479-11484.
31. Bertsova Y.V., Bogachev A.V. The origin of the sodium-dependent NADH oxidation by the respiratory chain of Klebsiella pneumoniae. FEBS Letters 2004, 563:207-212.
32. Betts J.C., Lukey P.T., Robb L.C., McAdam R.A., Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Molecular Microbiology 2002, 43:717-731.
33. Biagini G.A., Viriyavejakul P., O'Neill P.M., Bray P.G., Ward S.A. Functional characterization and target validation of alternative complex I of Plasmodium falciparum mitochondria. Antimicrobial Agents and Chemotherapy 2006, 50:1841-1851.
34. Birkholz S., Knipp U. Fumarate reductase of Helicobacter pylori-An immunogenic protein. Journal of Medical Microbiology 1994, 41:56-62.
35. Bliska J.B., van der Velden A.W. Salmonella "sops" up a preferred electron receptor in the inflamed intestine. mBio 2012, 3:e00226-12.
36. Borisov V.B., Forte E., Sarti P., Giuffre A. Catalytic intermediates of cytochrome bd terminal oxidase at steady-state: Ferryl and oxy-ferrous species dominate. Biochimica et Biophysica Acta 2011, 1807:503-509.
37. Borisov V.B., Gennis R.B., Hemp J., Verkhovsky M.I. The cytochrome bd respiratory oxygen reductases. Biochimica et Biophysica Acta 2011, 1807:1398-1413.
38. Borisov V., Gennis R., Konstantinov A.A. Peroxide complex of cytochrome bd: Kinetics of generation and stability. International Journal of Biochemistry and Molecular Biology 1995, 37:975-982.
39. Bott M., Meyer M., Dimroth P. Regulation of anaerobic citrate metabolism in Klebsiella pneumoniae. Molecular Microbiology 1995, 18:533-546.
40. Boucher H.W., Talbot G.H., Benjamin D.K., Bradley J., Guidos R.J., Jones R.N., et al. 10×20 Progress-Development of new drugs active against gram-negative bacilli: An update from the Infectious Diseases Society of America. Clinical Infectious Diseases 2013, 56:1685-1694.
41. Bowman L., Flanagan L., Fyfe P.K., Parkin A., Hunter W.N., Sargent F. How the structure of the large subunit controls function in an oxygen-tolerant [NiFe]-hydrogenase. Biochemical Journal 2014, 458:449-458.
42. Brown M.H., Paulsen I.T., Skurray R.A. The multidrug efflux protein NorM is a prototype of a new family of transporters. Molecular Microbiology 1999, 31:394-395.
43. Buckel W. Sodium ion-translocating decarboxylases. Biochimica et Biophysica Acta 2001, 1505:15-27.
44. + translocating ferredoxin oxidation. Biochimica et Biophysica Acta 2013, 1827:94-113.
45. Burke K.A., Lascelles J. Nitrate reductase system in Staphylococcus aureus wild type and mutants. Journal of Bacteriology 1975, 123:308-316.
46. 3 cytochrome oxidase provides insights into proton pumping. Science 2010, 329:327-330.
47. Calhoun M.W., Oden K.L., Gennis R.B., de Mattos M.J., Neijssel O.M. Energetic efficiency of Escherichia coli: Effects of mutations in components of the aerobic respiratory chain. Journal of Bacteriology 1993, 175:3020-3025.
48. Cardinale J.A., Clark V.L. Determinants of nitric oxide steady-state levels during anaerobic respiration by Neisseria gonorrhoeae. Molecular Microbiology 2005, 58:177-188.
49. Chen M., Andersen L.P., Zhai L., Kharazmi A. Characterization of the respiratory chain of Helicobacter pylori. FEMS Immunology and Medical Microbiology 1999, 24:169-174.
50. Chen M., Jensen B., Zhai L., Colding H., Kharazmi A., Kristiansen J.E., et al. Nizatidine and omeprazole enhance the effect of metronidazole on Helicobacter pylori in vitro. International Journal of Antimicrobial Agents 2002, 19:195-200.
51. Chen F., Xia Q., Ju L.K. Aerobic denitrification of Pseudomonas aeruginosa monitored by online NAD(P)H fluorescence. Applied and Environmental Microbiology 2003, 69:6715-6722.
52. 1) from Escherichia coli in an autoinhibited conformation. Nature Structural & Molecular Biology 2011, 18:701-707.
53. Cole S.T., Eiglmeier K., Parkhill J., James K.D., Thomson N.R., Wheeler P.R., et al. Massive gene decay in the leprosy bacillus. Nature 2001, 409:1007-1011.
54. Collins M.D., Jones D. Distribution of isoprenoid quinone structural types in distribution of isoprenoid quinone structural types in bacteria and their taxonomic implications. Microbiological Reviews 1981, 45:316-354.
55. 3 cytochrome oxidases. Molecular Microbiology 2004, 51:1193-1203.
56. Contreras M., Thiberge J.M., Mandrand-Berthelot M.A., Labigne A. Characterization of the roles of NikR, a nickel-responsive pleiotropic autoregulator of Helicobacter pylori. Molecular Microbiology 2003, 49:947-963.
57. Cook G.M., Hards K., Vilchèze C., Hartman T., Berney M. Energetics of respiration and oxidative phosphorylation in mycobacteria. Molecular genetics of mycobacteria 2014, ASM Press, Washington, DC. G. Hatfull, W.R. Jacobs (Eds.).
58. Cotter P.A., Chepuri V., Gennis R.B., Gunsalus R.P. Cytochrome o (cyoABCDE) and d (cydAB) oxidase gene expression in Escherichia coli is regulated by oxygen, pH, and the fnr gene product. Journal of Bacteriology 1990, 172:6333-6338.
59. 1-ATPase operon in the acid tolerance response. International Journal of Food Microbiology 2000, 60:137-146.
60. Cotter P.A., Melville S.B., Albrecht J.A., Gunsalus R.P. Aerobic regulation of cytochrome d oxidase (cydAB) operon expression in Escherichia coli: Roles of Fnr and ArcA in repression and activation. Molecular Microbiology 1997, 25:605-615.
61. Cox R.A., Cook G.M. Growth regulation in the mycobacterial cell. Current Molecular Medicine 2007, 7:231-245.
62. Cunningham L., Pitt M., Williams H.D. The cioAB genes from Pseudomonas aeruginosa code for a novel cyanide-insensitive terminal oxidase related to the cytochrome bd quinol oxidases. Molecular Microbiology 1997, 24:579-591.
63. da Silva S.M., Venceslau S.S., Fernandes C.L., Valente F.M., Pereira I.A. Hydrogen as an energy source for the human pathogen Bilophila wadsworthia. Antonie Van Leeuwenhoek 2008, 93:381-390.
64. de Jonge M.R., Koymans L.H., Guillemont J.E., Koul A., Andries K. A computational model of the inhibition of Mycobacterium tuberculosis ATPase by a new drug candidate R207910. Proteins 2007, 67:971-980.
65. Debnath J., Siricilla S., Wan B., Crick D.C., Lenaerts A.J., Franzblau S.G., et al. Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis. Journal of Medicinal Chemistry 2012, 55:3739-3755.
66. +/glutamate symport carrier gene of Escherichia coli B. Journal of Biological Chemistry 1990, 265:21704-21708.
67. Dhiman R.K., Mahapatra S., Slayden R.A., Boyne M.E., Lenaerts A., Hinshaw J.C., et al. Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence. Molecular Microbiology 2009, 72:85-97.
68. + pump. EMBO Journal 1996, 15:1842-1849.
69. Dimroth P. A new sodium-transport system energized by the decarboxylation of oxaloacetate. FEBS Letters 1980, 122:234-236.
70. Dimroth P. Bacterial sodium ion-coupled energetics. Antonie Van Leeuwenhoek 1994, 65:381-395.
71. +-coupled ATP synthases operating at low electrochemical potential. Advances in Microbial Physiology 2004, 49:175-218.
72. Dimroth P., Thomer A. On the mechanism of sodium ion translocation by oxaloacetate decarboxylase of Klebsiella pneumoniae. Biochemistry 1993, 32:1734-1739.
73. m values for oxygen are in the submicromolar range. Journal of Bacteriology 1995, 177:867-870.
74. D'Mello R., Hill S., Poole R.K. The cytochrome bd quinol oxidase in Escherichia coli has an extremely high oxygen affinity and two oxygen-binding haems: Implications for regulation of activity in vivo by oxygen inhibition. Microbiology 1996, 142:755-763.
75. Doering C., Ermentrout B., Oster G. Rotary DNA motors. Biophysical Journal 1995, 69:2256-2267.
76. Encheva V., Shah H.N., Gharbia S.E. Proteomic analysis of the adaptive response of Salmonella enterica serovar Typhimurium to growth under anaerobic conditions. Microbiology 2009, 155:2429-2441.
77. Endley S., McMurray D., Ficht T.A. Interruption of the cydB locus in Brucella abortus attenuates intracellular survival and virulence in the mouse model of infection. Journal of Bacteriology 2001, 183:2454-2462.
78. Eoh H., Rhee K.Y. Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:6554-6559.
79. Farha M.A., Verschoor C.P., Bowdish D., Brown E.D. Collapsing the proton motive force to identify synergistic combinations against Staphylococcus aureus. Chemistry & Biology 2013, 20:1168-1178.
80. 1 ATPase is essential for the viability of Streptococcus pneumoniae. FEMS Microbiology Letters 2002, 212:133-138.
81. Filiatrault M.J., Wagner V.E., Bushnell D., Haidaris C.G., Iglewski B.H., Passador L. Effect of anaerobiosis and nitrate on gene expression in Pseudomonas aeruginosa. Infection and Immunity 2005, 73:3764-3772.
82. Fink R.C., Evans M.R., Porwollik S., Vazquez-Torres A., Jones-Carson J., Troxell B., et al. FNR is a global regulator of virulence and anaerobic metabolism in Salmonella enterica serovar Typhimurium (ATCC 14028s). Journal of Bacteriology 2007, 189:2262-2273.
83. Frampton R., Aggio R.B., Villas-Boas S.G., Arcus V.L., Cook G.M. Toxin-antitoxin systems of Mycobacterium smegmatis are essential for cell survival. Journal of Biological Chemistry 2012, 287:5340-5356.
84. Fraser C.M., Norris S.J., Weinstock G.M., White O., Sutton G.G., Dodson R., et al. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 1998, 281:375-388.
85. 0 subunits of the ATP synthase of Escherichia coli K12. The EMBO Journal 1983, 2:99-103.
86. Fuchs S., Pane-Farre J., Kohler C., Hecker M., Engelmann S. Anaerobic gene expression in Staphylococcus aureus. Journal of Bacteriology 2007, 189:4275-4289.
87. Galagan J.E., Minch K., Peterson M., Lyubetskaya A., Azizi E., Sweet L., et al. The Mycobacterium tuberculosis regulatory network and hypoxia. Nature 2013, 499:178-183.
88. Gaupp R., Schlag S., Liebeke M., Lalk M., Götz F. Advantage of upregulation of succinate dehydrogenase in Staphylococcus aureus biofilms. Journal of Bacteriology 2010, 192:2385-2394.
89. Ge Z., Feng Y., Dangler C.A., Xu S., Taylor N.S., Fox J.G. Fumarate reductase is essential for Helicobacter pylori colonization of the mouse stomach. Microbial Pathogenesis 2000, 29:279-287.
90. Ge Z., Jiang Q., Kalisiak M.S., Taylor D.E. Cloning and functional characterization of Helicobacter pylori fumarate reductase operon comprising three structural genes coding for subunits C, A and B. Gene 1997, 204:227-234.
91. Gilberthorpe N.J., Poole R.K. Nitric oxide homeostasis in Salmonella typhimurium: Roles of respiratory nitrate reductase and flavohemoglobin. Journal of Biological Chemistry 2008, 283:11146-11154.
92. Giuffre A., Borisov V.B., Arese M., Sarti P., Forte E. Cytochrome bd oxidase and bacterial tolerance to oxidative and nitrosative stress. Biochimica et Biophysica Acta 2014, 1837:1178-1187.
93. Giuffre A., Borisov V.B., Mastronicola D., Sarti P., Forte E. Cytochrome bd oxidase and nitric oxide: From reaction mechanisms to bacterial physiology. FEBS Letters 2012, 586:622-629.
94. Glasser N.R., Kern S.E., Newman D.K. Phenazine redox cycling enhances anaerobic survival in Pseudomonas aeruginosa by facilitating generation of ATP and a proton-motive force. Molecular Microbiology 2014, 92:399-412.
95. Goldman B.S., Gabbert K.K., Kranz R.G. The temperature-sensitive growth and survival phenotypes of Escherichia coli cydDC and cydAB strains are due to deficiencies in cytochrome bd and are corrected by exogenous catalase and reducing agents. Journal of Bacteriology 1996, 178:6348-6351.
96. Goldstein E.J., Citron D.M., Peraino V.A., Cross S.A. Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections. Journal of Clinical Microbiology 2003, 41:2752-2754.
97. Greening C., Cook G.M. Integration of hydrogenase expression and hydrogen sensing in bacterial cell physiology. Current Opinion in Microbiology 2014, 18:30-38.
98. Griffin J.E., Gawronski J.D., Dejesus M.A., Ioerger T.R., Akerley B.J., Sassetti C.M. High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathogens 2011, 7:e1002251.
99. Griffin J.E., Pandey A.K., Gilmore S.A., Mizrahi V., McKinney J.D., Bertozzi C.R., et al. Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. Chemistry & Biology 2012, 19:218-227.
100. Guccione E., Hitchcock A., Hall S.J., Mulholland F., Shearer N., van Vliet A.H.M., et al. Reduction of fumarate, mesaconate and crotonate by Mfr, a novel oxygen-regulated periplasmic reductase in Campylobacter jejuni. Environmental Microbiology 2010, 12:576-591.
101. Guest J.R. Partial replacement of succinate dehydrogenase function by phage- and plasmid-specified fumarate reductase in Escherichia coli. Microbiology 1981, 122:171-179.
102. Gusarov I., Nudler E. NO-mediated cytoprotection: Instant adaptation to oxidative stress in bacteria. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:13855-13860.
103. Gusarov I., Shatalin K., Starodubtseva M., Nudler E. Endogenous nitric oxide protects bacteria against a wide spectrum of antibiotics. Science 2009, 325:1380-1384.
104. Haagsma A.C., Podasca I., Koul A., Andries K., Guillemont J., Lill H., et al. Probing the interaction of the diarylquinoline TMC207 with its target mycobacterial ATP synthase. PLoS One 2011, 6:e23575.
105. Hägerhäll C., Hederstedt L. A structural model for the membrane-integral domain of succinate: Quinone oxidoreductases. FEBS Letters 1996, 389:25-31.
106. Hall H.K., Karem K.L., Foster J.W. Molecular responses of microbes to environmental pH stress. Advances in Microbial Physiology 1995, 37:229-272.
107. Hammer N.D., Reniere M.L., Cassat J.E., Zhang Y., Hirsch A.O., Indriati Hood M., et al. Two heme-dependent terminal oxidases power Staphylococcus aureus organ-specific colonization of the vertebrate host. mBio 2013, 4:e00241-13.
108. Häse C.C., Barquera B. Role of sodium bioenergetics in Vibrio cholerae. Biochimica et Biophysica Acta 2001, 1505:169-178.
109. Häse C.C., Fedorova N.D., Galperin M.Y., Dibrov P.A. Sodium ion cycle in bacterial pathogens: Evidence from cross-genome comparisons. Microbiology and Molecular Biology Reviews 2001, 65:353-370.
110. Häse C.C., Mekalanos J.J. Effects of changes in membrane sodium flux on virulence gene expression in Vibrio cholerae. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:3183-3187.
111. +-translocating NADH-quinone reductase. Archives of Biochemistry and Biophysics 2002, 401:173-177.
112. He H., Bretl D.J., Penoske R.M., Anderson D.M., Zahrt T.C. Components of the Rv0081-Rv0088 locus, which encodes a predicted formate hydrogenlyase complex, are coregulated by Rv0081, MprA, and DosR in Mycobacterium tuberculosis. Journal of Bacteriology 2011, 193:5105-5118.
113. 2. Science 1999, 284:1941-1942.
114. Heikal A., Nakatani Y., Dunn E., Weimar M.R., Day C.L., Baker E.N., et al. Structure of the bacterial type II NADH dehydrogenase: A monotopic membrane protein with an essential role in energy generation. Molecular Microbiology 2014, 91:950-964.
115. Hensel M., Hinsley A.P., Nikolaus T., Sawers G., Berks B.C. The genetic basis of tetrathionate respiration in Salmonella typhimurium. Molecular Microbiology 1999, 32:275-287.
116. Herrmann G., Jayamani E., Mai G., Buckel W. Energy conservation via electron-transferring flavoprotein in anaerobic bacteria. Journal of Bacteriology 2008, 190:784-791.
117. + antiporters in survival of Vibrio cholerae in a saline environment. Journal of Bacteriology 2003, 185:1236-1244.
118. Hildebrandt T.M., Grieshaber M.K. Three enzymatic activities catalyze the oxidation of sulfide to thiosulfate in mammalian and invertebrate mitochondria. FEBS Journal 2008, 275:3352-3361.
119. Hiratsuka T., Furihata K., Ishikawa J., Yamashita H., Itoh N., Seto H., et al. An alternative menaquinone biosynthetic pathway operating in microorganisms. Science 2008, 321:1670-1673.
120. Hoffman P.S., Goodman T.G. Respiratory physiology and energy conservation efficiency of Campylobacter jejuni. Journal of Bacteriology 1982, 150:319-326.
121. Holden J.K., Li H., Jing Q., Kang S., Richo J., Silverman R.B., et al. Structural and biological studies on bacterial nitric oxide synthase inhibitors. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:18127-18131.
122. Hong S., Pedersen P.L. ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas. Microbiology and Molecular Biology Reviews 2008, 72:590-641.
123. 3 from Neisseria gonorrhoeae. FEMS Microbiology Letters 2009, 301:232-240.
124. Householder T.C., Fozo E.M., Cardinale J.A., Clark V.L. Gonococcal nitric oxide reductase is encoded by a single gene, norB, which is required for anaerobic growth and is induced by nitric oxide. Infection and Immunity 2000, 68:5241-5246.
125. Huang Y., Suyemoto M., Garner C.D., Cicconi K.M., Altier C. Formate acts as a diffusible signal to induce Salmonella invasion. Journal of Bacteriology 2008, 190:4233-4241.
126. +-driven multidrug efflux pump VcmA from Vibrio cholerae Non-O1, a non-halophilic bacterium. FEMS Microbiology Letters 2001, 203:235-239.
127. Huitric E., Verhasselt P., Andries K., Hoffner S.E. In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor. Antimicrobial Agents and Chemotherapy 2007, 51:4202-4204.
128. Huitric E., Verhasselt P., Koul A., Andries K., Hoffner S., Andersson D.I. Rates and mechanisms of resistance development in Mycobacterium tuberculosis to a novel diarylquinoline ATP synthase inhibitor. Antimicrobial Agents and Chemotherapy 2010, 54:1022-1028.
129. Hurdle J.G., O'Neill A.J., Chopra I., Lee R.E. Targeting bacterial membrane function: An underexploited mechanism for treating persistent infections. Nature Reviews. Microbiology 2011, 9:62-75.
130. Iuchi S., Chepuri V., Fu H.A., Gennis R.B., Lin E.C. Requirement for terminal cytochromes in generation of the aerobic signal for the arc regulatory system in Escherichia coli: Study utilizing deletions and lac fusions of cyo and cyd. Journal of Bacteriology 1990, 172:6020-6025.
131. Jackson R.J., Elvers K.T., Lee L.J., Gidley M.D., Wainwright L.M., Lightfoot J., et al. Oxygen reactivity of both respiratory oxidases in Campylobacter jejuni: The cydAB genes encode a cyanide-resistant, low-affinity oxidase that is not of the cytochrome bd type. Journal of Bacteriology 2007, 189:1604-1615.
132. Jamieson D.J., Sawers R.G., Rugman P.A., Boxer D.H., Higgins C.F. Effects of anaerobic regulatory mutations and catabolite repression on regulation of hydrogen metabolism and hydrogenase isoenzyme composition in Salmonella typhimurium. Journal of Bacteriology 1986, 168:405-411.
133. Jewes L.A., Spencer R.C. The incidence of anaerobes in the sputum of patients with cystic fibrosis. Journal of Medical Microbiology 1990, 31:271-274.
134. Jormakka M., Byrne B., Iwata S. Formate dehydrogenase-A versatile enzyme in changing environments. Current Opinion in Structural Biology 2003, 13:418-423.
135. Jormakka M., Byrne B., Iwata S. Protonmotive force generation by a redox loop mechanism. FEBS Letters 2003, 545:25-30.
136. Jormakka M., Tornroth S., Byrne B., Iwata S. Molecular basis of proton motive force generation: Structure of formate dehydrogenase-N. Science 2002, 295:1863-1868.
137. Jorth P., Trivedi U., Rumbaugh K., Whiteley M. Probing bacterial metabolism during infection using high-resolution transcriptomics. Journal of Bacteriology 2013, 195:4991-4998.
138. +-pumping NADH:quinone oxidoreductase. Biochimica et Biophysica Acta 2012, 1817:1823-1832.
139. Junemann S. Cytochrome bd terminal oxidase. Biochimica et Biophysica Acta 1997, 1321:107-127.
140. Jung J.Y., Madan-Lala R., Georgieva M., Rengarajan J., Sohaskey C.D., Bange F.C., et al. The intracellular environment of human macrophages that produce nitric oxide promotes growth of mycobacteria. Infection and Immunity 2013, 81:3198-3209.
141. +-translocating ATPase in Enterococcus hirae. Journal of Bioenergetics and Biomembranes 1999, 31:7-14.
142. Kana B.D., Weinstein E.A., Avarbock D., Dawes S.S., Rubin H., Mizrahi V. Characterization of the cydAB-encoded cytochrome bd oxidase from Mycobacterium smegmatis. Journal of Bacteriology 2001, 183:7076-7086.
143. Kang S., Kim R.Y., Seo M.J., Lee S., Kim Y.M., Seo M., et al. Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug resistant antituberculosis agent. Journal of Medicinal Chemistry 2014, 57(12):5293-5305.
144. Kapatral V., Anderson I., Ivanova N., Reznik G., Los T., Lykidis A., et al. Genome sequence and analysis of the oral bacterium Fusobacterium nucleatum strain ATCC 25586. Journal of Bacteriology 2002, 184:2005-2018.
145. Kapralek F. The physiological role of tetrathionate respiration in growing Citrobacter. Journal of General Microbiology 1972, 71:133-139.
146. Kawakami T., Kuroki M., Ishii M., Igarashi Y., Arai H. Differential expression of multiple terminal oxidases for aerobic respiration in Pseudomonas aeruginosa. Environmental Microbiology 2010, 12:1399-1412.
147. Kerscher S., Drose S., Zickermann V., Brandt U. The three families of respiratory NADH dehydrogenases. Results and Problems in Cell Differentiation 2008, 45:185-222.
148. King G.M. Uptake of carbon monoxide and hydrogen at environmentally relevant concentrations by mycobacteria. Applied and Environmental Microbiology 2003, 69:7266-7272.
149. Knapp J.S., Clark V.L. Anaerobic growth of Neisseria gonorrhoeae coupled to nitrite reduction. Infection and Immunity 1984, 46:176-181.
150. Knuth K., Niesalla H., Hueck C.J., Fuchs T.M. Large-scale identification of essential Salmonella genes by trapping lethal insertions. Molecular Microbiology 2004, 51:1729-1744.
151. Knuuti J., Belevich G., Sharma V., Bloch D.A., Verkhovskaya M. A single amino acid residue controls ROS production in the respiratory complex I from Escherichia coli. Molecular Microbiology 2013, 90:1190-1200.
152. +-ATPase complex is essential for growth of Lactococcus lactis. Journal of Bacteriology 2000, 182:4738-4743.
153. + motive force. Journal of Bacteriology 1999, 181:1927-1930.
154. Kosono S., Haga K., Tomizawa R., Kajiyama Y., Hatano K., Takeda S., et al. Characterization of a multigene-encoded sodium/hydrogen antiporter (sha) from Pseudomonas aeruginosa: Its involvement in pathogenesis. Journal of Bacteriology 2005, 187:5242-5248.
155. Koul A., Dendouga N., Vergauwen K., Molenberghs B., Vranckx L., Willebrords R., et al. Diarylquinolines target subunit c of mycobacterial ATP synthase. Nature Chemical Biology 2007, 3:323-324.
156. Koul A., Vranckx L., Dendouga N., Balemans W., Van den Wyngaert I., Vergauwen K., et al. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis. Journal of Biological Chemistry 2008, 283:25273-25280.
157. Koul A., Vranckx L., Dhar N., Gohlmann H.W., Ozdemir E., Neefs J.M., et al. Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism. Nature Communications 2014, 5:3369.
158. + translocation by the NADH:ubiquinone oxidoreductase (complex I) from Klebsiella pneumoniae. Molecular Microbiology 1999, 33:590-598.
159. + antiporter from Vibrio parahaemolyticus. Journal of Bacteriology 1997, 179:7600-7602.
160. Kurosu M., Crick D.C. MenA is a promising drug target for developing novel lead molecules to combat Mycobacterium tuberculosis. Medicinal Chemistry 2009, 5:197-207.
161. Lamichhane-Khadka R., Kwiatkowski A., Maier R.J. The Hyb hydrogenase permits hydrogen-dependent respiratory growth of Salmonella enterica serovar Typhimurium. mBio 2010, 1:e00284-10.
162. Lancaster C.R. Succinate:quinone oxidoreductases-What can we learn from Wolinella succinogenes quinol:fumarate reductase?. FEBS Letters 2001, 504:133-141.
163. Lancaster C.R.D. The di-heme family of respiratory complex II enzymes. Biochimica et Biophysica Acta 2013, 1827:679-687.
164. Lancaster C.R.D., Haas A.H., Madej M.G., Mileni M. Recent progress on obtaining theoretical and experimental support for the "E-pathway hypothesis" of coupled transmembrane electron and proton transfer in dihaem-containing quinol:fumarate reductase. Biochimica et Biophysica Acta 2006, 1757:988-995.
165. Lancaster C.R., Kröger A. Succinate:quinone oxidoreductases: New insights from X-ray crystal structures. Biochimica et Biophysica Acta 2000, 1459:422-431.
166. Lane N., Allen J.F., Martin W. How did LUCA make a living? Chemiosmosis in the origin of life. Bioessays 2010, 32:271-280.
167. Lemos R.S., Fernandes A.S., Pereira M.M., Gomes C.M., Teixeira M. Quinol:fumarate oxidoreductases and succinate:quinone oxidoreductases: Phylogenetic relationships, metal centres and membrane attachment. Biochimica et Biophysica Acta 2002, 1553:158-170.
168. Li F., Hinderberger J., Seedorf H., Zhang J., Buckel W., Thauer R.K. Coupled ferredoxin and crotonyl coenzyme A (CoA) reduction with NADH catalyzed by the butyryl-CoA dehydrogenase/Etf complex from Clostridium kluyveri. Journal of Bacteriology 2008, 190:843-850.
169. Lindqvist A., Membrillo-Hernandez J., Poole R.K., Cook G.M. Roles of respiratory oxidases in protecting Escherichia coli K12 from oxidative stress. Antonie Van Leeuwenhoek 2000, 78:23-31.
170. Linnane S.J., Keatings V.M., Costello C.M., Moynihan J.B., O'Connor C.M., Fitzgerald M.X., et al. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 1998, 158:207-212.
171. Liu Y.W., Denkmann K., Kosciow K., Dahl C., Kelly D.J. Tetrathionate stimulated growth of Campylobacter jejuni identifies a new type of bi-functional tetrathionate reductase (TsdA) that is widely distributed in bacteria. Molecular Microbiology 2013, 88:173-188.
172. Loisel-Meyer S., Jimenez de Bagues M.P., Kohler S., Liautard J.P., Jubier-Maurin V. Differential use of the two high-oxygen-affinity terminal oxidases of Brucella suis for in vitro and intramacrophagic multiplication. Infection and Immunity 2005, 73:7768-7771.
173. Lopez C.A., Winter S.E., Rivera-Chavez F., Xavier M.N., Poon V., Nuccio S.P., et al. Phage-mediated acquisition of a type III secreted effector protein boosts growth of Salmonella by nitrate respiration. mBio 2012, 3:e00143-12.
174. Lounis N., Gevers T., Van den Berg J., Vranckx L., Andries K. ATP synthase inhibition of Mycobacterium avium is not bactericidal. Antimicrobial Agents and Chemotherapy 2009, 53:4927-4929.
175. Lounis N., Guillemont J., Veziris N., Koul A., Jarlier V., Andries K. R207910 (TMC207): A new antibiotic for the treatment of tuberculosis. Médecine et Maladies Infectieuses 2010, 40:383-390.
176. Lounis N., Veziris N., Chauffour A., Truffot-Pernot C., Andries K., Jarlier V. Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration. Antimicrobial Agents and Chemotherapy 2006, 50:3543-3547.
177. Lupp C., Robertson M.L., Wickham M.E., Sekirov I., Champion O.L., Gaynor E.C., et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host & Microbe 2007, 2:119-129.
178. MacMicking J.D., North R.J., LaCourse R., Mudgett J.S., Shah S.K., Nathan C.F. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:5243-5248.
179. Maier R.J. Use of molecular hydrogen as an energy substrate by human pathogenic bacteria. Biochemical Society Transactions 2005, 33:83-85.
180. Maier R.J., Fu C., Gilbert J., Moshiri F., Olson J., Plaut A.G. Hydrogen uptake hydrogenase in Helicobacter pylori. FEMS Microbiology Letters 1996, 141:71-76.
181. Maier R.J., Olczak A., Maier S., Soni S., Gunn J. Respiratory hydrogen use by Salmonella enterica serovar Typhimurium is essential for virulence. Infection and Immunity 2004, 72:6294-6299.
182. Maier L., Vyas R., Cordova C.D., Lindsay H., Schmidt T.S., Brugiroux S., et al. Microbiota-derived hydrogen fuels Salmonella typhimurium invasion of the gut ecosystem. Cell Host & Microbe 2013, 14:641-651.
183. Mak P.A., Rao S.P., Ping Tan M., Lin X., Chyba J., Tay J., et al. A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis. ACS Chemical Biology 2012, 7:1190-1197.
184. Maklashina E., Berthold D.A., Cecchini G. Anaerobic expression of Escherichia coli succinate dehydrogenase: Functional replacement of fumarate reductase in the respiratory chain during anaerobic growth. Journal of Bacteriology 1998, 180:5989-5996.
185. Malm S., Tiffert Y., Micklinghoff J., Schultze S., Joost I., Weber I., et al. The roles of the nitrate reductase NarGHJI, the nitrite reductase NirBD and the response regulator GlnR in nitrate assimilation of Mycobacterium tuberculosis. Microbiology 2009, 155:1332-1339.
186. Mason M.G., Shepherd M., Nicholls P., Dobbin P.S., Dodsworth K.S., Poole R.K., et al. Cytochrome bd confers nitric oxide resistance to Escherichia coli. Nature Chemical Biology 2009, 5:94-96.
187. Matin A., Zychlinsky E., Keyhan M., Sachs G. Capacity of Helicobacter pylori to generate ionic gradients at low pH is similar to that of bacteria which grow under strongly acidic conditions. Infection and Immunity 1996, 64:1434-1436.
188. 3 branch of the respiratory network in mycobacteria and network adaptation occurring in response to its disruption. Journal of Bacteriology 2005, 187:6300-6308.
189. Matsushita K., Shinagawa E., Adachi O., Ameyama M. o-Type cytochrome oxidase in the membrane of aerobically grown Pseudomonas aeruginosa. FEBS Letters 1982, 139:255-258.
190. McClelland M., Sanderson K.E., Spieth J., Clifton S.W., Latreille P., Courtney L., et al. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 2001, 413:852-856.
191. 0-ATPase from Helicobacter pylori. Infection and Immunity 1997, 65:2640-2647.
192. McNamara P.J., Proctor R.A. Staphylococcus aureus small colony variants, electron transport and persistent infections. International Journal of Antimicrobial Agents 2000, 14:117-122.
193. 3 interaction in the respiratory chain of Mycobacterium smegmatis. Microbiology 2006, 152:823-829.
194. Mellies J., Jose J., Meyer T.F. The Neisseria gonorrhoeae gene aniA encodes an inducible nitrite reductase. Molecular and General Genetics 1997, 256:525-532.
195. Melo A.M.P., Bandeiras T.M., Teixeira M. New insights into type II NAD(P)H:quinone oxidoreductases. Microbiology and Molecular Biology Reviews 2004, 68:603-616.
196. Mercado-Lubo R., Gauger E.J., Leatham M.P., Conway T., Cohen P.S. A Salmonella enterica serovar typhimurium succinate dehydrogenase/fumarate reductase double mutant is avirulent and immunogenic in BALB/c mice. Infection and Immunity 2008, 76:1128-1134.
197. Merrell D.S., Thompson L.J., Kim C.C., Mitchell H., Tompkins L.S., Lee A., et al. Growth phase-dependent response of Helicobacter pylori to iron starvation. Infection and Immunity 2003, 71:6510-6525.
198. Meunier B., Madgwick S.A., Reil E., Oettmeier W., Rich P.R. New inhibitors of the quinol oxidation sites of bacterial cytochromes bo and bd. Biochemistry 1995, 34:1076-1083.
199. Mills P.C., Rowley G., Spiro S., Hinton J.C., Richardson D.J. A combination of cytochrome c nitrite reductase (NrfA) and flavorubredoxin (NorV) protects Salmonella enterica serovar Typhimurium against killing by NO in anoxic environments. Microbiology 2008, 154:1218-1228.
200. Mobius K., Arias-Cartin R., Breckau D., Hannig A.L., Riedmann K., Biedendieck R., et al. Heme biosynthesis is coupled to electron transport chains for energy generation. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:10436-10441.
201. Mogi T., Kawakami T., Arai H., Igarashi Y., Matsushita K., Mori M., et al. Siccanin rediscovered as a species-selective succinate dehydrogenase inhibitor. Journal of Biochemistry 2009, 146:383-387.
202. Mogi T., Matsushita K., Murase Y., Kawahara K., Miyoshi H., Ui H., et al. Identification of new inhibitors for alternative NADH dehydrogenase (NDH-II). FEMS Microbiology Letters 2009, 291:157-161.
203. Mulkidjanian A.Y., Dibrov P., Galperin M.Y. The past and present of sodium energetics: May the sodium-motive force be with you. Biochimica et Biophysica Acta 2008, 1777:985-992.
204. Myers J.D., Kelly D.J. A sulphite respiration system in the chemoheterotrophic human pathogen Campylobacter jejuni. Microbiology 2005, 151:233-242.
205. Nagata K., Tsukita S., Tamura T., Sone N. A cb-type cytochrome-c oxidase terminates the respiratory chain in Helicobacter pylori. Microbiology 1996, 142:1757-1763.
206. Nie W., Tang H., Fang Z., Chen J., Chen H., Xiu Q. Hydrogenase: The next antibiotic target?. Clinical Science 2012, 122:575-580.
207. + exchanger isoforms. The American Journal of Physiology 1995, 268:C283-C296.
208. Nolan K.J., McGee D.J., Mitchell H.M., Kolesnikow T., Harro J.M., O'Rourke J., et al. In vivo behavior of a Helicobacter pylori SS1 nixA mutant with reduced urease activity. Infection and Immunity 2002, 70:685-691.
209. Ohman D.E., Chakrabarty A.M. Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin. Infection and Immunity 1982, 37:662-669.
210. Olson J.W., Maier R.J. Molecular hydrogen as an energy source for Helicobacter pylori. Science 2002, 298:1788-1790.
211. Olson J.W., Mehta N.S., Maier R.J. Requirement of nickel metabolism proteins HypA and HypB for full activity of both hydrogenase and urease in Helicobacter pylori. Molecular Microbiology 2001, 39:176-182.
212. Ordway D., Viveiros M., Leandro C., Arroz M.J., Amaral L. Intracellular activity of clinical concentrations of phenothiazines including thioridiazine against phagocytosed Staphylococcus aureus. International Journal of Antimicrobial Agents 2002, 20:34-43.
213. Ordway D., Viveiros M., Leandro C., Arroz M.J., Molnar J., Kristiansen J.E., et al. Chloropromazine has intracellular killing activity against phagocytosed Staphylococcus aureus at clinical concentrations. Journal of Infection and Chemotherapy 2002, 8:227-231.
214. Ordway D., Viveiros M., Leandro C., Bettencourt R., Almeida J., Martins M., et al. Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 2003, 47:917-922.
215. Otto R., Sonnenberg A.S., Veldkamp H., Konings W.N. Generation of an electrochemical proton gradient in Streptococcus cremoris by lactate efflux. Proceedings of the National Academy of Sciences of the United States of America 1980, 77:5502-5506.
216. Overton T.W., Whitehead R., Li Y., Snyder L.A., Saunders N.J., Smith H., et al. Coordinated regulation of the Neisseria gonorrhoeae-truncated denitrification pathway by the nitric oxide-sensitive repressor, NsrR, and nitrite-insensitive NarQ-NarP. Journal of Biological Chemistry 2006, 281:33115-33126.
217. + antiporters. Biochimica et Biophysica Acta 2001, 1505:144-157.
218. Palmer K.L., Brown S.A., Whiteley M. Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. Journal of Bacteriology 2007, 189:4449-4455.
219. Palmer K.L., Mashburn L.M., Singh P.K., Whiteley M. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. Journal of Bacteriology 2005, 187:5267-5277.
220. Park S.W., Song T., Kim S.Y., Kim E., Oh J.I., Eom C.Y., et al. Carbon monoxide dehydrogenase in mycobacteria possesses a nitric oxide dehydrogenase activity. Biochemical and Biophysical Research Communications 2007, 362:449-453.
221. 2 under aerobic conditions. FEBS Letters 2012, 586:536-544.
222. Pecsi I., Hards K., Ekayanaka N., Berney M., Hartman T., Jacobs W.R., et al. Essentiality of succinate dehydrogenase in Mycobacterium smegmatis and its role in the generation of the membrane potential under hypoxia. mBio 2014, 5:e01093-14.
223. Pereira M.M., Santana M., Teixeira M. A novel scenario for the evolution of haem-copper oxygen reductases. Biochimica et Biophysica Acta 2001, 1505:185-208.
224. Pethe K., Bifani P., Jang J., Kang S., Park S., Ahn S., et al. Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. Nature Medicine 2013, 19:1157-1160.
225. Pfenninger-Li X.D., Dimroth P. NADH formation by Na(+)-coupled reversed electron transfer in Klebsiella pneumoniae. Molecular Microbiology 1992, 6:1943-1948.
226. Pinto R., Harrison J.S., Hsu T., Jacobs W.R., Leyh T.S. Sulfite reduction in mycobacteria. Journal of Bacteriology 2007, 189:6714-6722.
227. 3 oxidases. Biochimica et Biophysica Acta 2004, 1655:388-399.
228. Pitson S.M., Mendz G.L., Srinivasan S., Hazell S.L. The tricarboxylic acid cycle of Helicobacter pylori. European Journal of Biochemistry 1999, 260:258-267.
229. Pittman M.S., Robinson H.C., Poole R.K. A bacterial glutathione transporter (Escherichia coli CydDC) exports reductant to the periplasm. Journal of Biological Chemistry 2005, 280:32254-32261.
230. Poole R.K. Nitric oxide and nitrosative stress tolerance in bacteria. Biochemical Society Transactions 2005, 33:176-180.
231. Poole R.K., Cook G.M. Redundancy of aerobic respiratory chains in bacteria? Routes, reasons and regulation. Advances in Microbial Physiology 2000, 43:165-224.
232. Poole R.K., Williams H.D. Formation of the 680nm-absorbing form of the cytochrome bd oxidase complex of Escherichia coli by reaction of hydrogen peroxide with the ferric form. FEBS Letters 1988, 231:243-246.
233. Proctor R.A., Kahl B., von Eiff C., Vaudaux P.E., Lew D.P., Peters G. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clinical Infectious Diseases 1998, 27:S68-S74.
234. Rao S.P., Alonso S., Rand L., Dick T., Pethe K. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:11945-11950.
235. Ray A., Williams H.D. The effects of mutation of the anr gene on the aerobic respiratory chain of Pseudomonas aeruginosa. FEMS Microbiology Letters 1997, 156:227-232.
236. Rivera-Chavez F., Winter S.E., Lopez C.A., Xavier M.N., Winter M.G., Nuccio S.P., et al. Salmonella uses energy taxis to benefit from intestinal inflammation. PLoS Pathogen 2013, 9:e1003267.
237. Roberts G., Vadrevu I.S., Madiraju M.V., Parish T. Control of CydB and GltA1 expression by the SenX3 RegX3 two component regulatory system of Mycobacterium tuberculosis. PLoS One 2011, 6:e21090.
238. Rock J.D., Mahnane M.R., Anjum M.F., Shaw J.G., Read R.C., Moir J.W. The pathogen Neisseria meningitidis requires oxygen, but supplements growth by denitrification. Nitrite, nitric oxide and oxygen control respiratory flux at genetic and metabolic levels. Molecular Microbiology 2005, 58:800-809.
239. Sassetti C.M., Boyd D.H., Rubin E.J. Genes required for mycobacterial growth defined by high density mutagenesis. Molecular Microbiology 2003, 48:77-84.
240. Sawers G. The hydrogenases and formate dehydrogenases of Escherichia coli. Antonie Van Leeuwenhoek 1994, 66:57-88.
241. Sawers R.G., Jamieson D.J., Higgins C.F., Boxer D.H. Characterization and physiological roles of membrane-bound hydrogenase isoenzymes from Salmonella typhimurium. Journal of Bacteriology 1986, 168:398-404.
242. Schelle M.W., Bertozzi C.R. Sulfate metabolism in mycobacteria. ChemBioChem 2006, 7:1516-1524.
243. Schlag S., Fuchs S., Nerz C., Gaupp R., Engelmann S., Liebeke M., et al. Characterization of the oxygen-responsive NreABC regulon of Staphylococcus aureus. Journal of Bacteriology 2008, 190:7847-7858.
244. Schnappinger D., Ehrt S., Voskuil M.I., Liu Y., Mangan J.A., Monahan I.M., et al. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: Insights into the phagosomal environment. Journal of Experimental Medicine 2003, 198:693-704.
245. +-driven ATP synthase membrane rotor with a two-carboxylate ion-coupling motif. PLoS Biology 2013, 11:e1001596.
246. Schurig-Briccio L.A., Yano T., Rubin H., Gennis R.B. Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines. Biochimica et Biophysica Acta 2014, 1837:954-963.
247. Sellars M.J., Hall S.J., Kelly D.J. Growth of Campylobacter jejuni supported by respiration of fumarate, nitrate, nitrite, trimethylamine-N-oxide, or dimethyl sulfoxide requires oxygen. Journal of Bacteriology 2002, 184:4187-4196.
248. Seto H., Jinnai Y., Hiratsuka T., Fukawa M., Furihata K., Itoh N., et al. Studies on a new biosynthetic pathway for menaquinone. Journal of the American Chemical Society 2008, 130:5614-5615.
249. Shatalin K., Gusarov I., Avetissova E., Shatalina Y., McQuade L.E., Lippard S.J., et al. Bacillus anthracis-derived nitric oxide is essential for pathogen virulence and survival in macrophages. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:1009-1013.
250. Shaw F.L., Mulholland F., Le Gall G., Porcelli I., Hart D.J., Pearson B.M., et al. Selenium-dependent biogenesis of formate dehydrogenase in Campylobacter jejuni is controlled by the fdhTU accessory genes. Journal of Bacteriology 2012, 194:3814-3823.
251. Shi L., Sohaskey C.D., Kana B.D., Dawes S., North R.J., Mizrahi V., et al. Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:15629-15634.
252. Shirude P.S., Paul P., Choudhury N.R., Kedari C., Bandodkar B., Ugarkar B.G. Quinolinyl pyrimidines: Potent inhibitors of NDH-2 as a novel class of anti-TB agents. ACS Medicinal Chemistry Letters 2012, 3:736-740.
253. Siegele D.A., Imlay K.R., Imlay J.A. The stationary-phase-exit defect of cydC (surB) mutants is due to the lack of a functional terminal cytochrome oxidase. Journal of Bacteriology 1996, 178:6091-6096.
254. Singh P.K., Schaefer A.L., Parsek M.R., Moninger T.O., Welsh M.J., Greenberg E.P. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000, 407:762-764.
255. Small J.L., O'Donoghue A.J., Boritsch E.C., Tsodikov O.V., Knudsen G.M., Vandal O., et al. Substrate specificity of MarP, a periplasmic protease required for resistance to acid and oxidative stress in Mycobacterium tuberculosis. Journal of Biological Chemistry 2013, 288(18):12489-12499.
256. Smart J.P., Cliff M.J., Kelly D.J. A role for tungsten in the biology of Campylobacter jejuni: Tungstate stimulates formate dehydrogenase activity and is transported via an ultra-high affinity ABC system distinct from the molybdate transporter. Molecular Microbiology 2009, 74:742-757.
257. Smith M.A., Finel M., Korolik V., Mendz G.L. Characteristics of the aerobic respiratory chains of the microaerophiles Campylobacter jejuni and Helicobacter pylori. Archives of Microbiology 2000, 174:1-10.
258. Sohaskey C.D. Regulation of nitrate reductase activity in Mycobacterium tuberculosis by oxygen and nitric oxide. Microbiology 2005, 151:3803-3810.
259. Sohaskey C.D. Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration. Journal of Bacteriology 2008, 190:2981-2986.
260. Sohaskey C.D., Wayne L.G. Role of narK2X and narGHJI in hypoxic upregulation of nitrate reduction by Mycobacterium tuberculosis. Journal of Bacteriology 2003, 185:7247-7256.
261. Spector M.P., Garcia del Portillo F., Bearson S.M., Mahmud A., Magut M., Finlay B.B., et al. The rpoS-dependent starvation-stress response locus stiA encodes a nitrate reductase (narZYWV) required for carbon-starvation-inducible thermotolerance and acid tolerance in Salmonella typhimurium. Microbiology 1999, 145:3035-3045.
262. Stecher B., Robbiani R., Walker A.W., Westendorf A.M., Barthel M., Kremer M., et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biology 2007, 5:2177-2189.
263. Stefanelli P., Colotti G., Neri A., Salucci M.L., Miccoli R., Di Leandro L., et al. Molecular characterization of nitrite reductase gene (aniA) and gene product in Neisseria meningitidis isolates: Is aniA essential for meningococcal survival?. IUBMB Life 2008, 60:629-636.
264. + translocation by bacterial NADH:quinone oxidoreductases: An extension to the complex-I family of primary redox pumps. Biochimica et Biophysica Acta 2001, 1505:45-56.
265. Stevanin T.M., Moir J.W., Read R.C. Nitric oxide detoxification systems enhance survival of Neisseria meningitidis in human macrophages and in nasopharyngeal mucosa. Infection and Immunity 2005, 73:3322-3329.
266. Stewart V. Biochemical Society Special Lecture. Nitrate- and nitrite-responsive sensors NarX and NarQ of proteobacteria. Biochemical Society Transactions 2003, 31:1-10.
267. Stock D., Leslie A.G.W., Walker J.E. Molecular architecture of the rotary motor in ATP synthase. Science 1999, 286:1700-1705.
268. Stoffels L., Krehenbrink M., Berks B.C., Unden G. Thiosulfate reduction in Salmonella enterica is driven by the proton motive force. Journal of Bacteriology 2012, 194:475-485.
269. Stutts M.J., Knowles M.R., Gatzy J.T., Boucher R.C. Oxygen consumption and ouabain binding sites in cystic fibrosis nasal epithelium. Pediatric Research 1986, 20:1316-1320.
270. Sun Y.H., de Jong M.F., den Hartigh A.B., Roux C.M., Rolan H.G., Tsolis R.M. The small protein CydX is required for function of cytochrome bd oxidase in Brucella abortus. Frontiers in Cellular and Infection Microbiology 2012, 2:47.
271. Tareen A.M., Dasti J.I., Zautner A.E., Gross U., Lugert R. Campylobacter jejuni proteins Cj0952c and Cj0951c affect chemotactic behaviour towards formic acid and are important for invasion of host cells. Microbiology 2010, 156:3123-3135.
272. Teh J.S., Yano T., Rubin H. Type II NADH:menaquinone oxidoreductase of Mycobacterium tuberculosis. Infectious Disorders Drug Targets 2007, 7:169-181.
273. Terry J.M., Pina S.E., Mattingly S.J. Role of energy metabolism in conversion of nonmucoid Pseudomonas aeruginosa to the mucoid phenotype. Infection and Immunity 1992, 60:1329-1335.
274. Thiennimitr P., Winter S.E., Winter M.G., Xavier M.N., Tolstikov V., Huseby D.L., et al. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:17480-17485.
275. Tokuda H., Unemoto T. A respiration-dependent primary sodium extrusion system functioning at alkaline pH in the marine bacterium Vibrio alginolyticus. Biochemical and Biophysical Research Communications 1981, 102:265-271.
276. + is translocated at NADH:quinone oxidoreductase segment in the respiratory chain of Vibrio alginolyticus. Journal of Biological Chemistry 1984, 259:7785-7790.
277. Tomb J.F., White O., Kerlavage A.R., Clayton R.A., Sutton G.G., Fleischmann R.D., et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997, 388:539-547.
278. o-ATP synthase of Mycobacterium smegmatis is essential for growth. Journal of Bacteriology 2005, 187:5023-5028.
279. Tran S.L., Rao M., Simmers C., Gebhard S., Olsson K., Cook G.M. Mutants of Mycobacterium smegmatis unable to grow at acidic pH in the presence of the protonophore carbonyl cyanide m-chlorophenylhydrazone. Microbiology 2005, 151:665-672.
280. Tsolis R.M., Adams L.G., Ficht T.A., Baumler A.J. Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves. Infection and Immunity 1999, 67:4879-4885.
281. Tunbridge A.J., Stevanin T.M., Lee M., Marriott H.M., Moir J.W., Read R.C., et al. Inhibition of macrophage apoptosis by Neisseria meningitidis requires nitric oxide detoxification mechanisms. Infection and Immunity 2006, 74:729-733.
282. Turner A.K., Barber L.Z., Wigley P., Muhammad S., Jones M.A., Lovell M.A., et al. Contribution of proton-translocating proteins to the virulence of Salmonella enterica serovars Typhimurium, Gallinarum, and Dublin in chickens and mice. Infection and Immunity 2003, 71:3392-3401.
283. Turrens J.F. Superoxide production by the mitochondrial respiratory chain. Bioscience Reports 1997, 17:3-8.
284. Ueda A., Wood T.K. Potassium and sodium transporters of Pseudomonas aeruginosa regulate virulence to barley. Applied Microbiology and Biotechnology 2008, 79:843-858.
285. Unden G., Bongaerts J. Alternative respiratory pathways of Escherichia coli: Energetics and transcriptional regulation in response to electron acceptors. Biochimica et Biophysica Acta 1997, 1320:217-234.
286. Unden G., Schirawski J. The oxygen-responsive transcriptional regulator FNR of Escherichia coli: The search for signals and reactions. Molecular Microbiology 1997, 25:205-210.
287. van der Rest M.E., Siewe R.M., Abee T., Schwarz E., Oesterhelt D., Konings W.N. Nucleotide sequence and functional properties of a sodium-dependent citrate transport system from Klebsiella pneumoniae. Journal of Biological Chemistry 1992, 267:8971-8976.
288. VanOrsdel C.E., Bhatt S., Allen R.J., Brenner E.P., Hobson J.J., Jamil A., et al. The Escherichia coli CydX protein is a member of the CydAB cytochrome bd oxidase complex and is required for cytochrome bd oxidase activity. Journal of Bacteriology 2013, 195:3640-3650.
289. Vegge C.S., Brondsted L., Li Y.P., Bang D.D., Ingmer H. Energy taxis drives Campylobacter jejuni toward the most favorable conditions for growth. Applied and Environmental Microbiology 2009, 75:5308-5314.
290. Velmurugan K., Chen B., Miller J.L., Azogue S., Gurses S., Hsu T., et al. Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells. PLoS Pathogens 2007, 3:e110.
291. Verkhovsky M.I., Bogachev A.V. Sodium-translocating NADH:quinone oxidoreductase as a redox-driven ion pump. Biochimica et Biophysica Acta 2010, 1797:738-746.
292. + ratio mediates coresistance to isoniazid and ethionamide in mycobacteria. Antimicrobial Agents and Chemotherapy 2005, 49:708-720.
293. + antiporter involved in environmental survival of Vibrio cholerae. Journal of Bacteriology 2000, 182:2937-2944.
294. von Ballmoos C., Cook G.M., Dimroth P. Unique rotary ATP synthase and its biological diversity. Annual Review of Biophysics 2008, 37:43-64.
295. von Eiff C. Staphylococcus aureus small colony variants: A challenge to microbiologists and clinicians. International Journal of Antimicrobial Agents 2008, 31:507-510.
296. Voskuil M.I., Schnappinger D., Visconti K.C., Harrell M.I., Dolganov G.M., Sherman D.R., et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. Journal of Experimental Medicine 2003, 198:705-713.
297. Wang H., Gunsalus R.P. The nrfA and nirB nitrite reductase operons in Escherichia coli are expressed differently in response to nitrate than to nitrite. Journal of Bacteriology 2000, 182:5813-5822.
298. Warman A.J., Rito T.S., Fisher N.E., Moss D.M., Berry N.G., O'Neill P.M., et al. Antitubercular pharmacodynamics of phenothiazines. The Journal of Antimicrobial Chemotherapy 2013, 68:869-880.
299. Watanabe S., Zimmermann M., Goodwin M.B., Sauer U., Barry C.E., Boshoff H.I. Fumarate reductase activity maintains an energized membrane in anaerobic Mycobacterium tuberculosis. PLoS Pathogens 2011, 7:e1002287.
300. Way S.S., Sallustio S., Magliozzo R.S., Goldberg M.B. Impact of either elevated or decreased levels of cytochrome bd expression on Shigella flexneri virulence. Journal of Bacteriology 1999, 181:1229-1237.
301. Weerakoon D.R., Borden N.J., Goodson C.M., Grimes J., Olson J.W. The role of respiratory donor enzymes in Campylobacter jejuni host colonization and physiology. Microbial Pathogenesis 2009, 47:8-15.
302. Weerakoon D.R., Olson J.W. The Campylobacter jejuni NADH:ubiquinone oxidoreductase (complex I) utilizes flavodoxin rather than NADH. Journal of Bacteriology 2008, 190:915-925.
303. Weingarten R.A., Taveirne M.E., Olson J.W. The dual-functioning fumarate reductase is the sole succinate:quinone reductase in Campylobacter jejuni and is required for full host colonization. Journal of Bacteriology 2009, 191:5293-5300.
304. Weinstein E.A., Yano T., Li L.S., Avarbock D., Avarbock A., Helm D., et al. Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:4548-4553.
305. Wessel A.K., Arshad T.A., Fitzpatrick M., Connell J.L., Bonnecaze R.T., Shear J.B., et al. Oxygen limitation within a bacterial aggregate. mBio 2014, 5:e00992.
306. Whitehead R.N., Overton T.W., Snyder L.A., McGowan S.J., Smith H., Cole J.A., et al. The small FNR regulon of Neisseria gonorrhoeae: Comparison with the larger Escherichia coli FNR regulon and interaction with the NarQ-NarP regulon. BMC Genomics 2007, 8:35.
307. Williams H.D., Zlosnik J.E., Ryall B. Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa. Advances in Microbial Physiology 2007, 52:1-71.
308. Winter S.E., Baumler A.J. A breathtaking feat: To compete with the gut microbiota, Salmonella drives its host to provide a respiratory electron acceptor. Gut Microbes 2011, 2:58-60.
309. Winter S.E., Thiennimitr P., Winter M.G., Butler B.P., Huseby D.L., Crawford R.W., et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 2010, 467:426-429.
310. Winter S.E., Winter M.G., Xavier M.N., Thiennimitr P., Poon V., Keestra A.M., et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 2013, 339:708-711.
311. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. The Journal of Clinical Investigation 2002, 109:317-325.
312. Yano T., Li L.S., Weinstein E., Teh J.S., Rubin H. Steady-state kinetics and inhibitory action of antitubercular phenothiazines on Mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2). Journal of Biological Chemistry 2006, 281:11456-11463.
313. Ye R.W., Haas D., Ka J.O., Krishnapillai V., Zimmermann A., Baird C., et al. Anaerobic activation of the entire denitrification pathway in Pseudomonas aeruginosa requires Anr, an analog of Fnr. Journal of Bacteriology 1995, 177:3606-3609.
314. Yimga M.T., Leatham M.P., Allen J.H., Laux D.C., Conway T., Cohen P.S. Role of gluconeogenesis and the tricarboxylic acid cycle in the virulence of Salmonella enterica serovar typhimurium in BALB/c mice. Infection and Immunity 2006, 74:1130-1140.
315. 1-ATPase from a thermophilic eubacterium Thermus thermophilus. Journal of Biological Chemistry 1994, 269:12248-12253.
316. +-driven flagellar motor of Vibrio. Biochimica et Biophysica Acta 2001, 1505:82-93.
317. +-translocating NADH:quinone reductase from the marine Vibrio alginolyticus. Journal of Antibiotics 1999, 52:182-185.
318. Zacharia V.M., Manzanillo P.S., Nair V.R., Marciano D.K., Kinch L.N., Grishin N.V., et al. cor, a novel carbon monoxide resistance gene, is essential for Mycobacterium tuberculosis pathogenesis. mBio 2013, 4:e00721-13.
319. Zbell A.L., Benoit S.L., Maier R.J. Differential expression of NiFe uptake-type hydrogenase genes in Salmonella enterica serovar Typhimurium. Microbiology 2007, 153:3508-3516.
320. 2 in Salmonella enterica serovar Typhimurium. Applied and Environmental Microbiology 2009, 75:1456-1459.
321. Zbell A.L., Maier S.E., Maier R.J. Salmonella enterica serovar Typhimurium NiFe uptake-type hydrogenases are differentially expressed in vivo. Infection and Immunity 2008, 76:4445-4454.
322. Zhang Y.J., Ioerger T.R., Huttenhower C., Long J.E., Sassetti C.M., Sacchettini J.C., et al. Global assessment of genomic regions required for growth in Mycobacterium tuberculosis. PLoS Pathogens 2012, 8:e1002946.
323. Zhang-Barber L., Turner A.K., Martin G., Frankel G., Dougan G., Barrow P.A. Influence of genes encoding proton-translocating enzymes on suppression of Salmonella typhimurium growth and colonization. Journal of Bacteriology 1997, 179:7186-7190.